Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status
Samo za registrovane korisnike
2019
Autori
Milosavljević, FilipBukvić, Nikola
Pešić, Vesna
Pavlović, Zorana
Miljević, Čedo
Molden, Espen
Ingelman-Sundberg, Magnus
Jukić, Marin
Konferencijski prilog (Objavljena verzija)
Metapodaci
Prikaz svih podataka o dokumentuKljučne reči:
Antidepressant / Antipsychotic / Pharmacokinetics / Pharmacogenetics / Precision Medicine Neuropsychiatric DiseasesIzvor:
Neuropsychopharmacology, 2019, 44, 139-Izdavač:
- Springer Nature
Napomena:
- ACNP 58th Annual Meeting: Poster Session
DOI: 10.1038/s41386-019-0545-y
ISSN: 0893-133X
PubMed: 31801976
WoS: 000509665600273
[ Google Scholar ]Institucija/grupa
PharmacyTY - CONF AU - Milosavljević, Filip AU - Bukvić, Nikola AU - Pešić, Vesna AU - Pavlović, Zorana AU - Miljević, Čedo AU - Molden, Espen AU - Ingelman-Sundberg, Magnus AU - Jukić, Marin PY - 2019 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4752 PB - Springer Nature C3 - Neuropsychopharmacology T1 - Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status IS - 44 SP - 139 DO - 10.1038/s41386-019-0545-y ER -
@conference{ author = "Milosavljević, Filip and Bukvić, Nikola and Pešić, Vesna and Pavlović, Zorana and Miljević, Čedo and Molden, Espen and Ingelman-Sundberg, Magnus and Jukić, Marin", year = "2019", publisher = "Springer Nature", journal = "Neuropsychopharmacology", title = "Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status", number = "44", pages = "139", doi = "10.1038/s41386-019-0545-y" }
Milosavljević, F., Bukvić, N., Pešić, V., Pavlović, Z., Miljević, Č., Molden, E., Ingelman-Sundberg, M.,& Jukić, M.. (2019). Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status. in Neuropsychopharmacology Springer Nature.(44), 139. https://doi.org/10.1038/s41386-019-0545-y
Milosavljević F, Bukvić N, Pešić V, Pavlović Z, Miljević Č, Molden E, Ingelman-Sundberg M, Jukić M. Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status. in Neuropsychopharmacology. 2019;(44):139. doi:10.1038/s41386-019-0545-y .
Milosavljević, Filip, Bukvić, Nikola, Pešić, Vesna, Pavlović, Zorana, Miljević, Čedo, Molden, Espen, Ingelman-Sundberg, Magnus, Jukić, Marin, "Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status" in Neuropsychopharmacology, no. 44 (2019):139, https://doi.org/10.1038/s41386-019-0545-y . .